Notably, 96.9% (29/30) of adjacent normal breast tissues and 83.3% (25/30) of benign tumor tissues exhibited low COL11A1 mRNA expression levels, in contrast to 81.3% (87/107) of primary breast cancer samples which demonstrated high COL11A1 mRNA expression. This evidence concerns the gene COL11A1 and breast carcinoma.